Rank | Gene Set | Z-score |
---|---|---|
1 | cell wall macromolecule catabolic process (GO:0016998) | 5.55760570 |
2 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 5.30669821 |
3 | cell wall macromolecule metabolic process (GO:0044036) | 5.28501217 |
4 | neuronal action potential propagation (GO:0019227) | 5.23120076 |
5 | aggressive behavior (GO:0002118) | 5.22782241 |
6 | synaptic vesicle exocytosis (GO:0016079) | 5.19473938 |
7 | vocalization behavior (GO:0071625) | 4.95535085 |
8 | neuron cell-cell adhesion (GO:0007158) | 4.92524564 |
9 | glutamate secretion (GO:0014047) | 4.92078907 |
10 | protein localization to synapse (GO:0035418) | 4.81585876 |
11 | definitive hemopoiesis (GO:0060216) | 4.76496508 |
12 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.73630126 |
13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.66843869 |
14 | presynaptic membrane assembly (GO:0097105) | 4.63630464 |
15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.61238350 |
16 | positive regulation of histone H3-K4 methylation (GO:0051571) | 4.58695559 |
17 | glutamate receptor signaling pathway (GO:0007215) | 4.57745057 |
18 | rRNA methylation (GO:0031167) | 4.52337178 |
19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.42801546 |
20 | neuron-neuron synaptic transmission (GO:0007270) | 4.42074355 |
21 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.39886951 |
22 | presynaptic membrane organization (GO:0097090) | 4.38164355 |
23 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.33093678 |
24 | positive regulation of glycolytic process (GO:0045821) | 4.31345980 |
25 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.31171498 |
26 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.31171498 |
27 | rRNA modification (GO:0000154) | 4.27632343 |
28 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.18461602 |
29 | synaptic transmission, glutamatergic (GO:0035249) | 4.17072086 |
30 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.11804583 |
31 | negative regulation of gluconeogenesis (GO:0045721) | 4.11787050 |
32 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.09354812 |
33 | behavioral response to cocaine (GO:0048148) | 4.04738904 |
34 | histamine secretion (GO:0001821) | 4.01376924 |
35 | response to histamine (GO:0034776) | 4.01009171 |
36 | transferrin transport (GO:0033572) | 3.98243993 |
37 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.97422298 |
38 | organelle membrane fusion (GO:0090174) | 3.96327421 |
39 | regulation of synaptic vesicle transport (GO:1902803) | 3.95250762 |
40 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.93996178 |
41 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.93121933 |
42 | autophagic vacuole fusion (GO:0000046) | 3.91619614 |
43 | nitric oxide mediated signal transduction (GO:0007263) | 3.89494239 |
44 | DNA deamination (GO:0045006) | 3.89162291 |
45 | negative regulation of acute inflammatory response (GO:0002674) | 3.87736381 |
46 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.86646149 |
47 | neuron recognition (GO:0008038) | 3.82013259 |
48 | regulation of B cell apoptotic process (GO:0002902) | 3.81524024 |
49 | long-term synaptic potentiation (GO:0060291) | 3.78756917 |
50 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.75532744 |
51 | negative regulation of neurological system process (GO:0031645) | 3.72955913 |
52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.72206000 |
53 | maternal behavior (GO:0042711) | 3.71486650 |
54 | ferric iron transport (GO:0015682) | 3.70358180 |
55 | trivalent inorganic cation transport (GO:0072512) | 3.70358180 |
56 | inositol phosphate catabolic process (GO:0071545) | 3.69147460 |
57 | inositol phosphate dephosphorylation (GO:0046855) | 3.64927728 |
58 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.64927728 |
59 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.62622667 |
60 | behavioral fear response (GO:0001662) | 3.62062526 |
61 | behavioral defense response (GO:0002209) | 3.62062526 |
62 | regulation of glutamate secretion (GO:0014048) | 3.60800570 |
63 | cellular ketone body metabolic process (GO:0046950) | 3.60373128 |
64 | negative regulation of protein oligomerization (GO:0032460) | 3.57279501 |
65 | parental behavior (GO:0060746) | 3.56560941 |
66 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.56347688 |
67 | positive regulation of synapse maturation (GO:0090129) | 3.55877654 |
68 | axonal fasciculation (GO:0007413) | 3.55744458 |
69 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.55296648 |
70 | negative regulation of dendrite development (GO:2000171) | 3.54919756 |
71 | proline transport (GO:0015824) | 3.54651490 |
72 | postsynaptic membrane organization (GO:0001941) | 3.51522220 |
73 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.50754819 |
74 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.47126570 |
75 | positive regulation of vasculogenesis (GO:2001214) | 3.46886224 |
76 | endothelium development (GO:0003158) | 3.46851424 |
77 | neurotransmitter secretion (GO:0007269) | 3.46135266 |
78 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.45307938 |
79 | branched-chain amino acid catabolic process (GO:0009083) | 3.44762921 |
80 | synaptic vesicle maturation (GO:0016188) | 3.41166407 |
81 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.39359915 |
82 | fear response (GO:0042596) | 3.36476136 |
83 | protein localization to cilium (GO:0061512) | 3.35341778 |
84 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.33987380 |
85 | regulation of synaptic plasticity (GO:0048167) | 3.30939397 |
86 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.29483469 |
87 | exploration behavior (GO:0035640) | 3.29234117 |
88 | endocrine pancreas development (GO:0031018) | 3.28627011 |
89 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.26436449 |
90 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.25122365 |
91 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.23943729 |
92 | glucosamine-containing compound catabolic process (GO:1901072) | 3.23909937 |
93 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.23406885 |
94 | branched-chain amino acid metabolic process (GO:0009081) | 3.20969404 |
95 | seminiferous tubule development (GO:0072520) | 3.19618968 |
96 | ATP synthesis coupled proton transport (GO:0015986) | 3.19525269 |
97 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.19525269 |
98 | insulin secretion (GO:0030073) | 3.19211612 |
99 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.18608065 |
100 | regulation of vesicle fusion (GO:0031338) | 3.17719894 |
101 | long term synaptic depression (GO:0060292) | 3.17561882 |
102 | membrane depolarization (GO:0051899) | 3.16853743 |
103 | xenobiotic catabolic process (GO:0042178) | 3.15988394 |
104 | chemosensory behavior (GO:0007635) | 3.15755304 |
105 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.15472959 |
106 | ketone body metabolic process (GO:1902224) | 3.14678956 |
107 | positive regulation of neurotransmitter transport (GO:0051590) | 3.14006575 |
108 | histamine transport (GO:0051608) | 3.12734260 |
109 | positive regulation of membrane potential (GO:0045838) | 3.12255105 |
110 | synaptic vesicle endocytosis (GO:0048488) | 3.11558178 |
111 | * serotonin receptor signaling pathway (GO:0007210) | 3.10850821 |
112 | regulation of neurotransmitter secretion (GO:0046928) | 3.10145277 |
113 | locomotory exploration behavior (GO:0035641) | 3.09851461 |
114 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.09758810 |
115 | detection of calcium ion (GO:0005513) | 3.08656521 |
116 | striatum development (GO:0021756) | 3.06935713 |
117 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.06847129 |
118 | regulation of synapse structural plasticity (GO:0051823) | 3.05125034 |
119 | chaperone-mediated protein transport (GO:0072321) | 3.04717025 |
120 | urinary tract smooth muscle contraction (GO:0014848) | 3.04224938 |
121 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.03991296 |
122 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.03991296 |
123 | type B pancreatic cell development (GO:0003323) | 3.03179137 |
124 | dentate gyrus development (GO:0021542) | 3.02565885 |
125 | NADH metabolic process (GO:0006734) | 3.01596290 |
126 | estrogen biosynthetic process (GO:0006703) | 2.97431774 |
127 | regulation of protein kinase A signaling (GO:0010738) | 2.97062607 |
128 | positive regulation of insulin secretion (GO:0032024) | 2.96951055 |
129 | phagosome maturation (GO:0090382) | 2.96566341 |
130 | protein K6-linked ubiquitination (GO:0085020) | 2.96268680 |
131 | serotonin metabolic process (GO:0042428) | 2.95977941 |
132 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.95509458 |
133 | membrane depolarization during action potential (GO:0086010) | 2.95492377 |
134 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.93865488 |
135 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.92860667 |
136 | gamma-aminobutyric acid transport (GO:0015812) | 2.92734698 |
137 | negative regulation of synaptic transmission (GO:0050805) | 2.91644171 |
138 | cerebellar granule cell differentiation (GO:0021707) | 2.91415665 |
139 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.90779747 |
140 | positive regulation of muscle hypertrophy (GO:0014742) | 2.90779747 |
141 | mechanosensory behavior (GO:0007638) | 2.90643823 |
142 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.89524172 |
143 | startle response (GO:0001964) | 2.89486869 |
144 | neurotransmitter transport (GO:0006836) | 2.88475698 |
145 | * synaptic transmission (GO:0007268) | 2.87442755 |
146 | valine metabolic process (GO:0006573) | 2.87424164 |
147 | regulation of protein glycosylation (GO:0060049) | 2.86743158 |
148 | positive regulation of peptide hormone secretion (GO:0090277) | 2.86104679 |
149 | GPI anchor biosynthetic process (GO:0006506) | 2.85735681 |
150 | transmission of nerve impulse (GO:0019226) | 2.84173398 |
151 | learning (GO:0007612) | 2.84008402 |
152 | positive regulation of synapse assembly (GO:0051965) | 2.82764401 |
153 | RNA destabilization (GO:0050779) | 2.78665263 |
154 | grooming behavior (GO:0007625) | 2.78626293 |
155 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.78004502 |
156 | regulation of transmission of nerve impulse (GO:0051969) | 2.77155078 |
157 | positive regulation of TOR signaling (GO:0032008) | 2.75920005 |
158 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.73077497 |
159 | positive regulation of granulocyte differentiation (GO:0030854) | 2.72821258 |
160 | positive regulation of peptide secretion (GO:0002793) | 2.72501163 |
161 | polyol catabolic process (GO:0046174) | 2.71556990 |
162 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.67208111 |
163 | regulation of glucokinase activity (GO:0033131) | 2.64048237 |
164 | regulation of hexokinase activity (GO:1903299) | 2.64048237 |
165 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.62049367 |
166 | mannosylation (GO:0097502) | 2.60691660 |
167 | positive regulation of respiratory burst (GO:0060267) | 2.58964795 |
168 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.58829066 |
169 | GPI anchor metabolic process (GO:0006505) | 2.58229790 |
170 | GMP metabolic process (GO:0046037) | 2.57495977 |
171 | zinc ion transmembrane transport (GO:0071577) | 2.56413152 |
172 | C-terminal protein lipidation (GO:0006501) | 2.55684885 |
173 | protein complex biogenesis (GO:0070271) | 2.55430783 |
174 | monoamine transport (GO:0015844) | 2.51440878 |
175 | cardiolipin metabolic process (GO:0032048) | 2.49080015 |
176 | protein K11-linked deubiquitination (GO:0035871) | 2.48886466 |
177 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.48716341 |
178 | purine nucleotide salvage (GO:0032261) | 2.48547742 |
179 | piRNA metabolic process (GO:0034587) | 2.47234842 |
180 | cytochrome complex assembly (GO:0017004) | 2.47023720 |
181 | glandular epithelial cell differentiation (GO:0002067) | 2.46960841 |
182 | positive regulation of protein homodimerization activity (GO:0090073) | 2.43941671 |
183 | purine-containing compound salvage (GO:0043101) | 2.43311759 |
184 | succinate metabolic process (GO:0006105) | 2.42986630 |
185 | regulation of histone H3-K4 methylation (GO:0051569) | 2.41857251 |
186 | regulation of vasculogenesis (GO:2001212) | 2.40922128 |
187 | cell differentiation involved in metanephros development (GO:0072202) | 2.40145140 |
188 | single strand break repair (GO:0000012) | 2.39042964 |
189 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.38834579 |
190 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.38833304 |
191 | regulation of penile erection (GO:0060405) | 2.36806013 |
192 | forebrain morphogenesis (GO:0048853) | 2.35969943 |
193 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.35886867 |
194 | zinc ion transport (GO:0006829) | 2.33524573 |
195 | azole transport (GO:0045117) | 2.33087057 |
196 | macroautophagy (GO:0016236) | 2.32492884 |
197 | lactate metabolic process (GO:0006089) | 2.32452202 |
198 | regulation of female receptivity (GO:0045924) | 2.31210369 |
199 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.27923149 |
200 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.27923149 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 7.39365494 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.02348352 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.46920748 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.80221752 |
5 | * TAF15_26573619_Chip-Seq_HEK293_Human | 3.34169204 |
6 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19361406 |
7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.95675096 |
8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.90342811 |
9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.89977090 |
10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.70049651 |
11 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.63679799 |
12 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62541809 |
13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.52767620 |
14 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.45869091 |
15 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.42153431 |
16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.40846982 |
17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.39643549 |
18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.39643549 |
19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.37870483 |
20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37360629 |
21 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.36767011 |
22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.36277107 |
23 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.24431787 |
24 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.23519757 |
25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.23436541 |
26 | P300_19829295_ChIP-Seq_ESCs_Human | 2.19446229 |
27 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.19345798 |
28 | VDR_22108803_ChIP-Seq_LS180_Human | 2.18222975 |
29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 2.07315239 |
30 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.06508185 |
31 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.99995988 |
32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.98877675 |
33 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.98414282 |
34 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.98154162 |
35 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.98044529 |
36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.93708725 |
37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.90857849 |
38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90163142 |
39 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.89425531 |
40 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88891286 |
41 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.85827461 |
42 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.85310975 |
43 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.82772403 |
44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.80165224 |
45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78953275 |
46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.77832257 |
47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.76952192 |
48 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.75568978 |
49 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.74065144 |
50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.73857755 |
51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.71405909 |
52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.69292758 |
53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69217406 |
54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.67169113 |
55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.64167423 |
56 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63755632 |
57 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59504437 |
58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.57360736 |
59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.55152278 |
60 | AR_20517297_ChIP-Seq_VCAP_Human | 1.52908500 |
61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52122076 |
62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.51231898 |
63 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.49487041 |
64 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.49255985 |
65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48802827 |
66 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.48664862 |
67 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.48524088 |
68 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.47069794 |
69 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.44789348 |
70 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.44442228 |
71 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.42652366 |
72 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.42006761 |
73 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.41598004 |
74 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.41515836 |
75 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.41471684 |
76 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.40365735 |
77 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.40365735 |
78 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.40070472 |
79 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.36342676 |
80 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.35661355 |
81 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.35297957 |
82 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.35091735 |
83 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.35091735 |
84 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34467308 |
85 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.34279556 |
86 | JUN_21703547_ChIP-Seq_K562_Human | 1.34176535 |
87 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.33610579 |
88 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.33300963 |
89 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32471702 |
90 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32301768 |
91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30058829 |
92 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.28990877 |
93 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.28912356 |
94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.27311282 |
95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.26454125 |
96 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.25075983 |
97 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23906567 |
98 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.23712470 |
99 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22715388 |
100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21864670 |
101 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21546038 |
102 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21370547 |
103 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.20579775 |
104 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19812978 |
105 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18815963 |
106 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.18422839 |
107 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.16943047 |
108 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16897617 |
109 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15126903 |
110 | KDM2B_26808549_Chip-Seq_REH_Human | 1.14970498 |
111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14703867 |
112 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13916971 |
113 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.13769595 |
114 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.13348552 |
115 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12440613 |
116 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.12011977 |
117 | MYB_26560356_Chip-Seq_TH2_Human | 1.11286410 |
118 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09912936 |
119 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.09716615 |
120 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09572397 |
121 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07900667 |
122 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.07198197 |
123 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.05697524 |
124 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.05399971 |
125 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05084190 |
126 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05067140 |
127 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05067140 |
128 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.03481230 |
129 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03427107 |
130 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03097165 |
131 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02699936 |
132 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02476511 |
133 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02298015 |
134 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.02270678 |
135 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.02171195 |
136 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02113643 |
137 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01772256 |
138 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01456669 |
139 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01210318 |
140 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01079971 |
141 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.00628902 |
142 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00570577 |
143 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.00366762 |
144 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.99527036 |
145 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99193503 |
146 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99141292 |
147 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.99118284 |
148 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98637374 |
149 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98486825 |
150 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98215995 |
151 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98215995 |
152 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.97226011 |
153 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96843711 |
154 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96211530 |
155 | AR_19668381_ChIP-Seq_PC3_Human | 0.95781807 |
156 | * EWS_26573619_Chip-Seq_HEK293_Human | 0.95633499 |
157 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95565638 |
158 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.95517661 |
159 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.93346074 |
160 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.92948066 |
161 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92848057 |
162 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.91730154 |
163 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90600985 |
164 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.88322554 |
165 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.87070565 |
166 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.85568055 |
167 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.84852389 |
168 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.84343629 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 5.74041070 |
2 | MP0004859_abnormal_synaptic_plasticity | 5.34110890 |
3 | MP0004270_analgesia | 4.31557403 |
4 | * MP0003635_abnormal_synaptic_transmissio | 3.92432637 |
5 | MP0001968_abnormal_touch/_nociception | 3.88075209 |
6 | MP0009745_abnormal_behavioral_response | 3.60917975 |
7 | MP0002064_seizures | 3.42944076 |
8 | MP0002736_abnormal_nociception_after | 3.38189429 |
9 | MP0002063_abnormal_learning/memory/cond | 3.31532671 |
10 | MP0009046_muscle_twitch | 3.25277846 |
11 | MP0003195_calcinosis | 3.12748591 |
12 | MP0002572_abnormal_emotion/affect_behav | 3.05718369 |
13 | MP0001501_abnormal_sleep_pattern | 2.83485135 |
14 | MP0002272_abnormal_nervous_system | 2.83128484 |
15 | MP0002734_abnormal_mechanical_nocicepti | 2.80324357 |
16 | MP0002735_abnormal_chemical_nociception | 2.72129888 |
17 | MP0003283_abnormal_digestive_organ | 2.66864992 |
18 | MP0005645_abnormal_hypothalamus_physiol | 2.56379646 |
19 | MP0001486_abnormal_startle_reflex | 2.47233526 |
20 | MP0001440_abnormal_grooming_behavior | 2.43866225 |
21 | MP0002396_abnormal_hematopoietic_system | 2.40884219 |
22 | MP0004147_increased_porphyrin_level | 2.38314522 |
23 | MP0003718_maternal_effect | 2.35408769 |
24 | MP0002067_abnormal_sensory_capabilities | 2.32129967 |
25 | MP0002837_dystrophic_cardiac_calcinosis | 2.14035016 |
26 | * MP0002733_abnormal_thermal_nociception | 2.13657435 |
27 | MP0002693_abnormal_pancreas_physiology | 2.11462831 |
28 | MP0005397_hematopoietic_system_phenotyp | 2.11374244 |
29 | MP0001545_abnormal_hematopoietic_system | 2.11374244 |
30 | MP0001529_abnormal_vocalization | 2.10569366 |
31 | MP0004808_abnormal_hematopoietic_stem | 2.09382773 |
32 | MP0006276_abnormal_autonomic_nervous | 2.05610130 |
33 | MP0005084_abnormal_gallbladder_morpholo | 2.04041452 |
34 | MP0006072_abnormal_retinal_apoptosis | 2.02769763 |
35 | MP0001944_abnormal_pancreas_morphology | 2.02199598 |
36 | * MP0001970_abnormal_pain_threshold | 2.01873089 |
37 | MP0005220_abnormal_exocrine_pancreas | 2.00803293 |
38 | MP0009697_abnormal_copulation | 1.90482555 |
39 | MP0005464_abnormal_platelet_physiology | 1.88582813 |
40 | MP0003806_abnormal_nucleotide_metabolis | 1.84863110 |
41 | MP0005379_endocrine/exocrine_gland_phen | 1.79327643 |
42 | MP0001984_abnormal_olfaction | 1.77407497 |
43 | MP0004924_abnormal_behavior | 1.77011940 |
44 | MP0005386_behavior/neurological_phenoty | 1.77011940 |
45 | MP0003656_abnormal_erythrocyte_physiolo | 1.76655656 |
46 | MP0003879_abnormal_hair_cell | 1.74612198 |
47 | MP0002184_abnormal_innervation | 1.71384524 |
48 | MP0003172_abnormal_lysosome_physiology | 1.71309722 |
49 | MP0000778_abnormal_nervous_system | 1.66454269 |
50 | MP0001905_abnormal_dopamine_level | 1.64545622 |
51 | MP0003329_amyloid_beta_deposits | 1.61094221 |
52 | MP0004142_abnormal_muscle_tone | 1.60176062 |
53 | MP0000516_abnormal_urinary_system | 1.55722826 |
54 | MP0005367_renal/urinary_system_phenotyp | 1.55722826 |
55 | MP0001764_abnormal_homeostasis | 1.53543890 |
56 | MP0003787_abnormal_imprinting | 1.52702789 |
57 | MP0002557_abnormal_social/conspecific_i | 1.51787469 |
58 | MP0008569_lethality_at_weaning | 1.46260303 |
59 | MP0002139_abnormal_hepatobiliary_system | 1.45011529 |
60 | MP0000465_gastrointestinal_hemorrhage | 1.41944120 |
61 | MP0004858_abnormal_nervous_system | 1.41393176 |
62 | MP0002066_abnormal_motor_capabilities/c | 1.40612371 |
63 | MP0001986_abnormal_taste_sensitivity | 1.40585190 |
64 | MP0004811_abnormal_neuron_physiology | 1.38922617 |
65 | MP0005636_abnormal_mineral_homeostasis | 1.36039696 |
66 | MP0002882_abnormal_neuron_morphology | 1.27171014 |
67 | MP0000955_abnormal_spinal_cord | 1.26337691 |
68 | MP0004484_altered_response_of | 1.26235721 |
69 | MP0001661_extended_life_span | 1.24792351 |
70 | MP0001835_abnormal_antigen_presentation | 1.22289753 |
71 | MP0002078_abnormal_glucose_homeostasis | 1.21697596 |
72 | MP0000751_myopathy | 1.21632907 |
73 | MP0002009_preneoplasia | 1.21019085 |
74 | MP0008872_abnormal_physiological_respon | 1.20416499 |
75 | MP0002876_abnormal_thyroid_physiology | 1.20230778 |
76 | MP0009780_abnormal_chondrocyte_physiolo | 1.16482057 |
77 | MP0003122_maternal_imprinting | 1.16097129 |
78 | MP0002166_altered_tumor_susceptibility | 1.15700788 |
79 | MP0008775_abnormal_heart_ventricle | 1.15504061 |
80 | MP0010386_abnormal_urinary_bladder | 1.14866566 |
81 | MP0005646_abnormal_pituitary_gland | 1.14278718 |
82 | MP0005171_absent_coat_pigmentation | 1.13023942 |
83 | MP0004145_abnormal_muscle_electrophysio | 1.11652511 |
84 | MP0010329_abnormal_lipoprotein_level | 1.11538601 |
85 | MP0005253_abnormal_eye_physiology | 1.11437381 |
86 | MP0003633_abnormal_nervous_system | 1.11099823 |
87 | MP0005423_abnormal_somatic_nervous | 1.10600199 |
88 | MP0002234_abnormal_pharynx_morphology | 1.08954525 |
89 | MP0002822_catalepsy | 1.08487684 |
90 | MP0001756_abnormal_urination | 1.06832812 |
91 | MP0001188_hyperpigmentation | 1.06613246 |
92 | MP0005332_abnormal_amino_acid | 1.06278480 |
93 | MP0000230_abnormal_systemic_arterial | 1.06263653 |
94 | MP0008874_decreased_physiological_sensi | 1.06240136 |
95 | MP0002160_abnormal_reproductive_system | 1.06054264 |
96 | MP0002909_abnormal_adrenal_gland | 1.05297894 |
97 | MP0005389_reproductive_system_phenotype | 1.04267822 |
98 | MP0002928_abnormal_bile_duct | 1.03680446 |
99 | MP0008875_abnormal_xenobiotic_pharmacok | 1.03301034 |
100 | MP0008058_abnormal_DNA_repair | 1.02731979 |
101 | MP0003252_abnormal_bile_duct | 1.01897067 |
102 | MP0003631_nervous_system_phenotype | 1.01244998 |
103 | MP0008995_early_reproductive_senescence | 1.00124416 |
104 | MP0003724_increased_susceptibility_to | 0.99478353 |
105 | MP0000681_abnormal_thyroid_gland | 0.99454316 |
106 | MP0003075_altered_response_to | 0.98497268 |
107 | MP0009643_abnormal_urine_homeostasis | 0.98234793 |
108 | MP0004215_abnormal_myocardial_fiber | 0.96772312 |
109 | MP0002118_abnormal_lipid_homeostasis | 0.96461817 |
110 | MP0004085_abnormal_heartbeat | 0.95681515 |
111 | MP0003943_abnormal_hepatobiliary_system | 0.95437385 |
112 | MP0004510_myositis | 0.94715773 |
113 | MP0000013_abnormal_adipose_tissue | 0.94541993 |
114 | MP0001963_abnormal_hearing_physiology | 0.94534060 |
115 | MP0003186_abnormal_redox_activity | 0.94483471 |
116 | MP0009278_abnormal_bone_marrow | 0.94137873 |
117 | MP0002152_abnormal_brain_morphology | 0.91992332 |
118 | MP0002229_neurodegeneration | 0.91833461 |
119 | MP0005394_taste/olfaction_phenotype | 0.91511071 |
120 | MP0005499_abnormal_olfactory_system | 0.91511071 |
121 | MP0003953_abnormal_hormone_level | 0.90152980 |
122 | MP0003121_genomic_imprinting | 0.90021084 |
123 | MP0002069_abnormal_eating/drinking_beha | 0.89615863 |
124 | MP0004742_abnormal_vestibular_system | 0.88415607 |
125 | MP0005395_other_phenotype | 0.87624343 |
126 | MP0010307_abnormal_tumor_latency | 0.86552603 |
127 | MP0000639_abnormal_adrenal_gland | 0.83280436 |
128 | MP0005535_abnormal_body_temperature | 0.83268669 |
129 | MP0002148_abnormal_hypersensitivity_rea | 0.83255784 |
130 | MP0005448_abnormal_energy_balance | 0.82720273 |
131 | MP0005075_abnormal_melanosome_morpholog | 0.82681936 |
132 | MP0002006_tumorigenesis | 0.80209089 |
133 | MP0004134_abnormal_chest_morphology | 0.80095865 |
134 | MP0000604_amyloidosis | 0.80036861 |
135 | MP0000427_abnormal_hair_cycle | 0.79928676 |
136 | MP0002163_abnormal_gland_morphology | 0.78328395 |
137 | MP0000689_abnormal_spleen_morphology | 0.77062360 |
138 | MP0008469_abnormal_protein_level | 0.76727379 |
139 | MP0001485_abnormal_pinna_reflex | 0.75574227 |
140 | MP0000003_abnormal_adipose_tissue | 0.75370091 |
141 | MP0008004_abnormal_stomach_pH | 0.75352447 |
142 | MP0006292_abnormal_olfactory_placode | 0.74955963 |
143 | MP0004036_abnormal_muscle_relaxation | 0.74614724 |
144 | MP0005165_increased_susceptibility_to | 0.74265654 |
145 | MP0001502_abnormal_circadian_rhythm | 0.73636320 |
146 | MP0002752_abnormal_somatic_nervous | 0.71391495 |
147 | MP0001664_abnormal_digestion | 0.71110759 |
148 | MP0005409_darkened_coat_color | 0.70573683 |
149 | MP0003646_muscle_fatigue | 0.68982462 |
150 | MP0003632_abnormal_nervous_system | 0.67273639 |
151 | MP0005551_abnormal_eye_electrophysiolog | 0.65743425 |
152 | MP0000920_abnormal_myelination | 0.62788878 |
153 | MP0003634_abnormal_glial_cell | 0.62170725 |
154 | MP0006035_abnormal_mitochondrial_morpho | 0.61925595 |
155 | MP0001765_abnormal_ion_homeostasis | 0.60890334 |
156 | MP0004885_abnormal_endolymph | 0.59494424 |
157 | MP0002751_abnormal_autonomic_nervous | 0.59234252 |
158 | MP0000026_abnormal_inner_ear | 0.58500752 |
159 | MP0005620_abnormal_muscle_contractility | 0.57516609 |
160 | MP0001727_abnormal_embryo_implantation | 0.56490001 |
161 | MP0005410_abnormal_fertilization | 0.56190305 |
162 | MP0000631_abnormal_neuroendocrine_gland | 0.54939160 |
163 | MP0000749_muscle_degeneration | 0.54567311 |
164 | MP0001943_abnormal_respiration | 0.54475369 |
165 | MP0006036_abnormal_mitochondrial_physio | 0.52283358 |
166 | MP0008877_abnormal_DNA_methylation | 0.51724553 |
167 | MP0004043_abnormal_pH_regulation | 0.50300199 |
168 | MP0001177_atelectasis | 0.50207896 |
169 | MP0002082_postnatal_lethality | 0.46548016 |
170 | MP0010770_preweaning_lethality | 0.46548016 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 9.52225474 |
2 | Focal seizures (HP:0007359) | 6.31418248 |
3 | Atonic seizures (HP:0010819) | 6.12310652 |
4 | Epileptic encephalopathy (HP:0200134) | 5.65492796 |
5 | Hypoglycemic seizures (HP:0002173) | 5.33358642 |
6 | Febrile seizures (HP:0002373) | 5.25686510 |
7 | Absence seizures (HP:0002121) | 5.05107215 |
8 | Hyperventilation (HP:0002883) | 4.96670048 |
9 | Dialeptic seizures (HP:0011146) | 4.94371888 |
10 | Myokymia (HP:0002411) | 4.84613700 |
11 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.83648006 |
12 | Visual hallucinations (HP:0002367) | 4.80549913 |
13 | Hypoglycemic coma (HP:0001325) | 4.61992310 |
14 | Generalized tonic-clonic seizures (HP:0002069) | 4.40614046 |
15 | Ketoacidosis (HP:0001993) | 4.33873818 |
16 | Hyperglycemia (HP:0003074) | 4.15922321 |
17 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.56064662 |
18 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.56064662 |
19 | Symptomatic seizures (HP:0011145) | 3.46881116 |
20 | Acute necrotizing encephalopathy (HP:0006965) | 3.46442543 |
21 | Broad-based gait (HP:0002136) | 3.45377302 |
22 | Amblyopia (HP:0000646) | 3.35078788 |
23 | Ketosis (HP:0001946) | 3.33110257 |
24 | Progressive cerebellar ataxia (HP:0002073) | 3.26954538 |
25 | Hyperthyroidism (HP:0000836) | 3.25492780 |
26 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.23734063 |
27 | Gaze-evoked nystagmus (HP:0000640) | 3.21933549 |
28 | Progressive macrocephaly (HP:0004481) | 3.07256194 |
29 | Attenuation of retinal blood vessels (HP:0007843) | 3.03657256 |
30 | Neoplasm of the adrenal cortex (HP:0100641) | 2.97268763 |
31 | Termporal pattern (HP:0011008) | 2.96961288 |
32 | Insidious onset (HP:0003587) | 2.96961288 |
33 | Mitochondrial inheritance (HP:0001427) | 2.92939620 |
34 | Abnormal hair whorl (HP:0010721) | 2.90771664 |
35 | Epileptiform EEG discharges (HP:0011182) | 2.89406993 |
36 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.86649244 |
37 | Lipid accumulation in hepatocytes (HP:0006561) | 2.86239914 |
38 | Poor eye contact (HP:0000817) | 2.82319535 |
39 | Testicular neoplasm (HP:0010788) | 2.80386925 |
40 | Gait imbalance (HP:0002141) | 2.80187914 |
41 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.79564495 |
42 | Truncal ataxia (HP:0002078) | 2.76999923 |
43 | Pheochromocytoma (HP:0002666) | 2.76253408 |
44 | Cerebral inclusion bodies (HP:0100314) | 2.75354787 |
45 | Thyroiditis (HP:0100646) | 2.65955693 |
46 | Medial flaring of the eyebrow (HP:0010747) | 2.65792520 |
47 | Excessive salivation (HP:0003781) | 2.65198651 |
48 | Drooling (HP:0002307) | 2.65198651 |
49 | Hypothermia (HP:0002045) | 2.64097452 |
50 | Inability to walk (HP:0002540) | 2.61843900 |
51 | Acute encephalopathy (HP:0006846) | 2.61389223 |
52 | Protruding tongue (HP:0010808) | 2.61140003 |
53 | Hematochezia (HP:0002573) | 2.60875286 |
54 | Congenital stationary night blindness (HP:0007642) | 2.60217301 |
55 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.59615599 |
56 | Congenital primary aphakia (HP:0007707) | 2.58757668 |
57 | Impaired social interactions (HP:0000735) | 2.57367216 |
58 | Abnormal social behavior (HP:0012433) | 2.57367216 |
59 | Abnormality of binocular vision (HP:0011514) | 2.57104112 |
60 | Diplopia (HP:0000651) | 2.57104112 |
61 | Neoplasm of the adrenal gland (HP:0100631) | 2.56014067 |
62 | Neuroendocrine neoplasm (HP:0100634) | 2.55791475 |
63 | Panhypogammaglobulinemia (HP:0003139) | 2.53800057 |
64 | EEG with generalized epileptiform discharges (HP:0011198) | 2.53147283 |
65 | Increased hepatocellular lipid droplets (HP:0006565) | 2.52729311 |
66 | Increased CSF lactate (HP:0002490) | 2.51966979 |
67 | Dysmetria (HP:0001310) | 2.51324295 |
68 | Nephrogenic diabetes insipidus (HP:0009806) | 2.50982286 |
69 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.50466181 |
70 | Absent speech (HP:0001344) | 2.50198683 |
71 | Abnormal eating behavior (HP:0100738) | 2.49910737 |
72 | Dicarboxylic aciduria (HP:0003215) | 2.49284208 |
73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.49284208 |
74 | 3-Methylglutaconic aciduria (HP:0003535) | 2.48937197 |
75 | Scanning speech (HP:0002168) | 2.46415566 |
76 | Late onset (HP:0003584) | 2.46228086 |
77 | Anxiety (HP:0000739) | 2.46138203 |
78 | Hepatocellular necrosis (HP:0001404) | 2.45703440 |
79 | Hydroureter (HP:0000072) | 2.44887854 |
80 | Glycosuria (HP:0003076) | 2.44857686 |
81 | Abnormality of urine glucose concentration (HP:0011016) | 2.44857686 |
82 | Methylmalonic acidemia (HP:0002912) | 2.43795240 |
83 | Dysdiadochokinesis (HP:0002075) | 2.43468495 |
84 | Dysmetric saccades (HP:0000641) | 2.41317081 |
85 | Agitation (HP:0000713) | 2.36200990 |
86 | Abnormality of macular pigmentation (HP:0008002) | 2.35692671 |
87 | Constricted visual fields (HP:0001133) | 2.34626026 |
88 | Generalized myoclonic seizures (HP:0002123) | 2.33607518 |
89 | Hypomagnesemia (HP:0002917) | 2.33546816 |
90 | Abnormal protein glycosylation (HP:0012346) | 2.33503213 |
91 | Abnormal glycosylation (HP:0012345) | 2.33503213 |
92 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.33503213 |
93 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.33503213 |
94 | Progressive inability to walk (HP:0002505) | 2.33147473 |
95 | Conjunctival hamartoma (HP:0100780) | 2.32102151 |
96 | Polydipsia (HP:0001959) | 2.31684751 |
97 | Abnormal drinking behavior (HP:0030082) | 2.31684751 |
98 | Sensory axonal neuropathy (HP:0003390) | 2.30477185 |
99 | Retinal dysplasia (HP:0007973) | 2.29426113 |
100 | Nephronophthisis (HP:0000090) | 2.28863445 |
101 | Increased serum pyruvate (HP:0003542) | 2.28582848 |
102 | Abnormality of glycolysis (HP:0004366) | 2.28582848 |
103 | Psychosis (HP:0000709) | 2.27665148 |
104 | Stomatitis (HP:0010280) | 2.27639999 |
105 | Status epilepticus (HP:0002133) | 2.27426912 |
106 | Furrowed tongue (HP:0000221) | 2.27061771 |
107 | Prolonged bleeding time (HP:0003010) | 2.26190216 |
108 | Impaired smooth pursuit (HP:0007772) | 2.25337885 |
109 | Acute lymphatic leukemia (HP:0006721) | 2.25243347 |
110 | Hypsarrhythmia (HP:0002521) | 2.24830565 |
111 | Blue irides (HP:0000635) | 2.23513544 |
112 | Reduced antithrombin III activity (HP:0001976) | 2.20435148 |
113 | Pancreatic fibrosis (HP:0100732) | 2.19461285 |
114 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.17535412 |
115 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.17388408 |
116 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.17388408 |
117 | Fair hair (HP:0002286) | 2.16222529 |
118 | Pancreatic cysts (HP:0001737) | 2.16197824 |
119 | Abnormality of vitamin B metabolism (HP:0004340) | 2.15214675 |
120 | Supranuclear gaze palsy (HP:0000605) | 2.14779023 |
121 | Delusions (HP:0000746) | 2.13691189 |
122 | Genital tract atresia (HP:0001827) | 2.13489693 |
123 | Hepatic necrosis (HP:0002605) | 2.13346346 |
124 | Resting tremor (HP:0002322) | 2.12890558 |
125 | Abnormality of the renal cortex (HP:0011035) | 2.12087698 |
126 | Vaginal atresia (HP:0000148) | 2.11702943 |
127 | Abnormality of the corticospinal tract (HP:0002492) | 2.11256071 |
128 | Polyphagia (HP:0002591) | 2.10180091 |
129 | Metaphyseal dysplasia (HP:0100255) | 2.09337805 |
130 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.08313703 |
131 | Abnormality of alanine metabolism (HP:0010916) | 2.08313703 |
132 | Hyperalaninemia (HP:0003348) | 2.08313703 |
133 | Increased intramyocellular lipid droplets (HP:0012240) | 2.07705740 |
134 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.06930430 |
135 | Action tremor (HP:0002345) | 2.06476337 |
136 | Increased muscle lipid content (HP:0009058) | 2.06120813 |
137 | Optic disc pallor (HP:0000543) | 2.04562775 |
138 | Hemiparesis (HP:0001269) | 2.02671703 |
139 | Petechiae (HP:0000967) | 2.01951782 |
140 | Decreased central vision (HP:0007663) | 2.01360482 |
141 | Prominent metopic ridge (HP:0005487) | 2.01243520 |
142 | Renal Fanconi syndrome (HP:0001994) | 2.00664984 |
143 | Calf muscle hypertrophy (HP:0008981) | 2.00481946 |
144 | Neurofibrillary tangles (HP:0002185) | 1.99886381 |
145 | Specific learning disability (HP:0001328) | 1.99656131 |
146 | Depression (HP:0000716) | 1.99062153 |
147 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.97459746 |
148 | Type I transferrin isoform profile (HP:0003642) | 1.97068620 |
149 | Generalized hypopigmentation of hair (HP:0011358) | 1.97056496 |
150 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.95705497 |
151 | Abnormality of salivation (HP:0100755) | 1.95483107 |
152 | Abnormal gallbladder physiology (HP:0012438) | 1.94322442 |
153 | Cholecystitis (HP:0001082) | 1.94322442 |
154 | Poor coordination (HP:0002370) | 1.93439777 |
155 | Incomplete penetrance (HP:0003829) | 1.92269186 |
156 | Poor suck (HP:0002033) | 1.92139702 |
157 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.91039356 |
158 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.91039356 |
159 | Fetal akinesia sequence (HP:0001989) | 1.90155075 |
160 | Abnormality of the renal medulla (HP:0100957) | 1.88146752 |
161 | Narrow nasal bridge (HP:0000446) | 1.88102730 |
162 | Impaired vibratory sensation (HP:0002495) | 1.87033819 |
163 | Impaired pain sensation (HP:0007328) | 1.86986601 |
164 | Abnormality of pain sensation (HP:0010832) | 1.86986601 |
165 | Renal cortical cysts (HP:0000803) | 1.86400674 |
166 | Methylmalonic aciduria (HP:0012120) | 1.85377065 |
167 | Stereotypic behavior (HP:0000733) | 1.84646557 |
168 | Leukodystrophy (HP:0002415) | 1.84407482 |
169 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.83881557 |
170 | Failure to thrive in infancy (HP:0001531) | 1.82587843 |
171 | Focal dystonia (HP:0004373) | 1.81987205 |
172 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.81893796 |
173 | X-linked dominant inheritance (HP:0001423) | 1.81834990 |
174 | Abolished electroretinogram (ERG) (HP:0000550) | 1.80578599 |
175 | Increased circulating renin level (HP:0000848) | 1.77086099 |
176 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.76992651 |
177 | Lethargy (HP:0001254) | 1.76400192 |
178 | Polyuria (HP:0000103) | 1.75031269 |
179 | Insulin resistance (HP:0000855) | 1.72819101 |
180 | Thrombocytosis (HP:0001894) | 1.72056434 |
181 | Alveolar cell carcinoma (HP:0006519) | 1.71816872 |
182 | Villous atrophy (HP:0011473) | 1.71585006 |
183 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.71585006 |
184 | Abnormality of B cell number (HP:0010975) | 1.69026357 |
185 | Opisthotonus (HP:0002179) | 1.68837505 |
186 | Cardiomegaly (HP:0001640) | 1.68577182 |
187 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.67851308 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 7.05599763 |
2 | RIPK4 | 5.52396831 |
3 | EPHA4 | 4.04398147 |
4 | CASK | 4.00904339 |
5 | MAP3K12 | 3.66136974 |
6 | NTRK3 | 3.21620602 |
7 | MAP3K4 | 3.06541278 |
8 | MAP2K7 | 3.00745365 |
9 | TAOK3 | 2.81928276 |
10 | CDK19 | 2.78631124 |
11 | BCKDK | 2.59251115 |
12 | BMPR2 | 2.49552823 |
13 | MAP3K9 | 2.49342357 |
14 | FGFR2 | 2.45045349 |
15 | SCYL2 | 2.44694874 |
16 | TRIM28 | 2.41128357 |
17 | PLK2 | 2.39098428 |
18 | NUAK1 | 2.38777924 |
19 | MAP4K2 | 2.36261562 |
20 | MKNK1 | 2.36068231 |
21 | DAPK1 | 2.30678596 |
22 | ARAF | 2.29312199 |
23 | MINK1 | 2.25381395 |
24 | KIT | 2.19020241 |
25 | NME1 | 2.15551133 |
26 | DAPK2 | 1.99937355 |
27 | MAP2K4 | 1.94626401 |
28 | ZAK | 1.94348989 |
29 | PINK1 | 1.82853069 |
30 | TEC | 1.81361087 |
31 | OXSR1 | 1.77812039 |
32 | GRK5 | 1.73481908 |
33 | TRPM7 | 1.64161595 |
34 | MAP2K6 | 1.62348548 |
35 | NME2 | 1.59061159 |
36 | TIE1 | 1.48891787 |
37 | PTK2B | 1.43116549 |
38 | MAPKAPK5 | 1.41008355 |
39 | KSR1 | 1.34670948 |
40 | NTRK1 | 1.33826417 |
41 | FGFR3 | 1.33756846 |
42 | FLT3 | 1.32561477 |
43 | MARK1 | 1.32478407 |
44 | EIF2AK3 | 1.30423737 |
45 | PRPF4B | 1.29268830 |
46 | PNCK | 1.28486466 |
47 | MAPK13 | 1.26405605 |
48 | CCNB1 | 1.21437925 |
49 | PAK6 | 1.20673679 |
50 | TLK1 | 1.17953670 |
51 | CAMK2B | 1.17652016 |
52 | CAMK2A | 1.17298838 |
53 | MAP2K3 | 1.16913772 |
54 | TNIK | 1.15556296 |
55 | PRKCG | 1.14687176 |
56 | PASK | 1.14370134 |
57 | CDK5 | 1.11819796 |
58 | CAMKK2 | 1.11459292 |
59 | MAP3K13 | 1.10497371 |
60 | IKBKE | 1.09461909 |
61 | KSR2 | 1.09394637 |
62 | BTK | 1.06209133 |
63 | PHKG2 | 1.05368308 |
64 | PHKG1 | 1.05368308 |
65 | PDK4 | 1.05365978 |
66 | PDK3 | 1.05365978 |
67 | GRK1 | 1.04741851 |
68 | NTRK2 | 1.04649103 |
69 | AKT3 | 1.04097127 |
70 | MAP4K1 | 1.00331670 |
71 | FGR | 0.97780147 |
72 | SIK3 | 0.97178169 |
73 | IKBKB | 0.94538195 |
74 | GRK6 | 0.93877349 |
75 | TSSK6 | 0.93531820 |
76 | ITK | 0.91152013 |
77 | FES | 0.90612308 |
78 | TBK1 | 0.90600249 |
79 | RAF1 | 0.89837833 |
80 | MYLK | 0.88290834 |
81 | CAMKK1 | 0.86296589 |
82 | INSRR | 0.85677902 |
83 | BRAF | 0.85631343 |
84 | MST4 | 0.84397709 |
85 | MAP3K5 | 0.82936677 |
86 | HIPK2 | 0.82318966 |
87 | PRKCE | 0.80601330 |
88 | PRKG2 | 0.79730861 |
89 | BCR | 0.79561985 |
90 | SGK223 | 0.78717352 |
91 | SGK494 | 0.78717352 |
92 | TXK | 0.78554869 |
93 | SGK2 | 0.74875324 |
94 | RPS6KA5 | 0.74125630 |
95 | VRK1 | 0.70814215 |
96 | MAP2K1 | 0.70762452 |
97 | MAP2K2 | 0.69344123 |
98 | MAP3K2 | 0.68780520 |
99 | TAF1 | 0.68747129 |
100 | DYRK1A | 0.68255579 |
101 | CDK18 | 0.67921992 |
102 | CSF1R | 0.67102087 |
103 | MAP3K14 | 0.65712048 |
104 | GRK7 | 0.65677040 |
105 | CAMK2D | 0.65452004 |
106 | CDK14 | 0.65371436 |
107 | FER | 0.64934545 |
108 | PIK3CG | 0.63705628 |
109 | CAMK2G | 0.61701159 |
110 | PDK2 | 0.60121455 |
111 | CDK15 | 0.59306391 |
112 | BMPR1B | 0.59152216 |
113 | PDK1 | 0.58707242 |
114 | PRKAA2 | 0.58273321 |
115 | DAPK3 | 0.58138772 |
116 | STK38L | 0.58051164 |
117 | STK3 | 0.56085695 |
118 | ADRBK1 | 0.55432894 |
119 | MATK | 0.54965022 |
120 | NLK | 0.54951692 |
121 | ROCK2 | 0.54563407 |
122 | UHMK1 | 0.53881510 |
123 | MAPK15 | 0.53196989 |
124 | CSNK1G1 | 0.52292377 |
125 | SGK1 | 0.51516455 |
126 | CSNK1G3 | 0.50784629 |
127 | YES1 | 0.50635159 |
128 | PDPK1 | 0.50618538 |
129 | RPS6KB2 | 0.49846253 |
130 | SIK2 | 0.49128002 |
131 | CDK11A | 0.48725295 |
132 | JAK3 | 0.47054204 |
133 | TNK2 | 0.46961009 |
134 | LYN | 0.46830737 |
135 | WNK4 | 0.45809794 |
136 | STK38 | 0.44517605 |
137 | PIM2 | 0.44032454 |
138 | MAP3K11 | 0.43354307 |
139 | MKNK2 | 0.42668194 |
140 | RET | 0.42445965 |
141 | IRAK1 | 0.42115680 |
142 | MAPK12 | 0.41288005 |
143 | LCK | 0.39317153 |
144 | ATM | 0.38356440 |
145 | PAK3 | 0.38216009 |
146 | MAPK7 | 0.38144792 |
147 | MAP3K1 | 0.37656280 |
148 | PRKACA | 0.37617405 |
149 | ERBB3 | 0.35366819 |
150 | ABL1 | 0.34808015 |
151 | TGFBR1 | 0.34419447 |
152 | MAP3K6 | 0.33301178 |
153 | ADRBK2 | 0.33276312 |
154 | CSNK2A2 | 0.32544924 |
155 | STK11 | 0.31922133 |
156 | SYK | 0.31708938 |
157 | PRKCQ | 0.31404791 |
158 | PLK3 | 0.31236904 |
159 | STK39 | 0.31083942 |
160 | PRKCA | 0.29385005 |
161 | PRKCB | 0.28831071 |
162 | PRKCH | 0.27455628 |
163 | MAP3K7 | 0.26783412 |
164 | RPS6KA3 | 0.26004518 |
165 | CAMK1 | 0.25579931 |
166 | FYN | 0.25213887 |
167 | PRKCZ | 0.24940500 |
168 | MUSK | 0.24884497 |
169 | CSNK1G2 | 0.24056245 |
170 | PRKG1 | 0.22859606 |
171 | PRKD3 | 0.22510577 |
172 | LATS2 | 0.22387266 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.27963144 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.06694538 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.51186774 |
4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.40463902 |
5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.89134242 |
6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.88724125 |
7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.77624024 |
8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.69473583 |
9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.61337183 |
10 | Morphine addiction_Homo sapiens_hsa05032 | 2.58890451 |
11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.56899964 |
12 | GABAergic synapse_Homo sapiens_hsa04727 | 2.53656742 |
13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.43047516 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37451766 |
15 | Olfactory transduction_Homo sapiens_hsa04740 | 2.35774879 |
16 | Protein export_Homo sapiens_hsa03060 | 2.33079179 |
17 | Salivary secretion_Homo sapiens_hsa04970 | 2.26401815 |
18 | * Taste transduction_Homo sapiens_hsa04742 | 2.16718199 |
19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.12268781 |
20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.07630284 |
21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.94811651 |
22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.89481381 |
23 | Peroxisome_Homo sapiens_hsa04146 | 1.87715700 |
24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.85412283 |
25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81181047 |
26 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.80908401 |
27 | Renin secretion_Homo sapiens_hsa04924 | 1.78698462 |
28 | Insulin secretion_Homo sapiens_hsa04911 | 1.77999671 |
29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.74210212 |
30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.70122149 |
31 | Long-term depression_Homo sapiens_hsa04730 | 1.65971800 |
32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.60820206 |
33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.53588649 |
34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.53063168 |
35 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.51817930 |
36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.51473772 |
37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.51012593 |
38 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.50854181 |
39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.44601573 |
40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.40101271 |
41 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.38012040 |
42 | Platelet activation_Homo sapiens_hsa04611 | 1.32769180 |
43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.32585025 |
44 | Asthma_Homo sapiens_hsa05310 | 1.31886790 |
45 | Huntingtons disease_Homo sapiens_hsa05016 | 1.31607902 |
46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.30388387 |
47 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.30383961 |
48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.28615967 |
49 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.28079312 |
50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28050814 |
51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.27153158 |
52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26986394 |
53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.26192818 |
54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.23880624 |
55 | Gap junction_Homo sapiens_hsa04540 | 1.18079190 |
56 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.17922704 |
57 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.16765349 |
58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.15573902 |
59 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.13874975 |
60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12674636 |
61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03352202 |
62 | Phototransduction_Homo sapiens_hsa04744 | 1.00681640 |
63 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00551790 |
64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99609016 |
65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98741095 |
66 | Cocaine addiction_Homo sapiens_hsa05030 | 0.95421831 |
67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95020718 |
68 | ABC transporters_Homo sapiens_hsa02010 | 0.94980528 |
69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92836238 |
70 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91064633 |
71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90639052 |
72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90419737 |
73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.90295190 |
74 | Purine metabolism_Homo sapiens_hsa00230 | 0.89343327 |
75 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.88186785 |
76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.87630023 |
77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.87129220 |
78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86760948 |
79 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.86197345 |
80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.84947524 |
81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.84346159 |
82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.83931181 |
83 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.82494849 |
84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80914194 |
85 | Homologous recombination_Homo sapiens_hsa03440 | 0.80601235 |
86 | Melanogenesis_Homo sapiens_hsa04916 | 0.80492827 |
87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.79245190 |
88 | Axon guidance_Homo sapiens_hsa04360 | 0.78616527 |
89 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78494539 |
90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77654065 |
91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76795594 |
92 | RNA degradation_Homo sapiens_hsa03018 | 0.76079437 |
93 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.75108150 |
94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75104619 |
95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74698182 |
96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.72872904 |
97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68319518 |
98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65820510 |
99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65811481 |
100 | Glioma_Homo sapiens_hsa05214 | 0.64407965 |
101 | Basal transcription factors_Homo sapiens_hsa03022 | 0.63164637 |
102 | Phagosome_Homo sapiens_hsa04145 | 0.62895584 |
103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62782369 |
104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62533943 |
105 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62336622 |
106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62011902 |
107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61087234 |
108 | Allograft rejection_Homo sapiens_hsa05330 | 0.60178993 |
109 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58230853 |
110 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.57408203 |
111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56844934 |
112 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56189507 |
113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55410465 |
114 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55327058 |
115 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53702499 |
116 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49300577 |
117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47111444 |
118 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.46926142 |
119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44235730 |
120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42316017 |
121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41681276 |
122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39316633 |
123 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.39116946 |
124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38944755 |
125 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.35715352 |
126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35657053 |
127 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.35517106 |
128 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.34386461 |
129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.33335308 |
130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32892333 |
131 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.32273871 |
132 | RNA polymerase_Homo sapiens_hsa03020 | 0.32228073 |
133 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32223733 |
134 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31626141 |
135 | Lysosome_Homo sapiens_hsa04142 | 0.30696138 |
136 | Sulfur relay system_Homo sapiens_hsa04122 | 0.30658682 |
137 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.29940271 |
138 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.29626914 |
139 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28897444 |
140 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28565366 |
141 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28545914 |
142 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27953540 |
143 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26874122 |
144 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.23597815 |
145 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.22916481 |
146 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.22523044 |
147 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19411293 |
148 | Bile secretion_Homo sapiens_hsa04976 | 0.19154126 |
149 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.19007967 |
150 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.18799387 |
151 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.17560701 |
152 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16632856 |
153 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.12594183 |
154 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.11359151 |
155 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.11201995 |
156 | Melanoma_Homo sapiens_hsa05218 | 0.10919386 |
157 | Alcoholism_Homo sapiens_hsa05034 | 0.10015446 |
158 | Prion diseases_Homo sapiens_hsa05020 | 0.09916381 |
159 | Circadian rhythm_Homo sapiens_hsa04710 | 0.09012242 |